Cargando…

The Role of Non-Coding RNAs in Myelodysplastic Neoplasms

SIMPLE SUMMARY: Myelodysplastic neoplasms (MDS) are a group of hematologic malignancies with an increased risk of transformation to acute myeloid leukemia. Non-coding RNAs are RNA molecules of variable size that do not translate into proteins but regulate gene expression during multiple cellular pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georgoulis, Vasileios, Koumpis, Epameinondas, Hatzimichael, Eleftheria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571949/ https://www.ncbi.nlm.nih.gov/pubmed/37835504 http://dx.doi.org/10.3390/cancers15194810

Ejemplares similares

Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
por: Hatzimichael, Eleftheria, et al.
Publicado: (2022)

Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020)

Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report
por: Koumpis, Epameinondas, et al.
Publicado: (2023)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
por: Georgoulis, Vasileios, et al.
Publicado: (2023)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Barakos, Georgios Petros, et al.
Publicado: (2022)

The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw
por: Calvete, Oriol, et al.
Publicado: (2023)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
por: Palomo, Laura, et al.
Publicado: (2021)

Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
por: Lulli, Matteo, et al.
Publicado: (2022)

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
por: Lucero, Josephine, et al.
Publicado: (2023)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
por: Hochman, Michael J., et al.
Publicado: (2021)

Regulation of Adaptive Tumor Immunity by Non-Coding RNAs
por: Papaioannou, Eleftheria, et al.
Publicado: (2021)

The Role of Non-Coding RNAs in Glioma
por: Goenka, Anshika, et al.
Publicado: (2022)

Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
por: Hebeda, Konnie M., et al.
Publicado: (2009)

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
por: Hoff, Fieke W., et al.
Publicado: (2023)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
por: Gerke, Margo B., et al.
Publicado: (2023)

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
por: Clara, Joseph A., et al.
Publicado: (2016)

The Impact of Clonal Hierarchy and Heterogeneity on Phenotypic Manifestations of Myelodysplastic Neoplasms
por: El Hussein, Siba, et al.
Publicado: (2022)

Role of MicroRNAs and Long Non-Coding RNAs in Sarcopenia
por: Lee, Jihui, et al.
Publicado: (2022)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation
por: Hatzimichael, Eleftheria, et al.
Publicado: (2010)

Functional roles of non-coding Y RNAs
por: Kowalski, Madzia P., et al.
Publicado: (2015)

The Role of Long Non-Coding RNAs in Hepatocarcinogenesis
por: Lanzafame, Manuela, et al.
Publicado: (2018)

The Role of Long Non-Coding RNAs in Osteosarcoma
por: Smolle, Maria Anna, et al.
Publicado: (2018)

The Role of Non-Coding RNAs in Uveal Melanoma
por: Bande, Manuel, et al.
Publicado: (2020)

Emerging roles of non‐coding RNAs in scoliosis
por: Li, Zheng, et al.
Publicado: (2019)

The Role of Long Non-Coding RNAs in Endometriosis
por: Hudson, Quanah J., et al.
Publicado: (2021)

The Role of Non-Coding RNAs in the Human Placenta
por: Žarković, Milena, et al.
Publicado: (2022)

How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Long non-coding RNAs: From disease code to drug role
por: Chen, Yuanyuan, et al.
Publicado: (2021)

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
por: Dranitsaris, George, et al.
Publicado: (2012)

Cancer Epigenetics: New Therapies and New Challenges
por: Hatzimichael, Eleftheria, et al.
Publicado: (2013)

Role of non-coding RNAs in plant immunity
por: Song, Li, et al.
Publicado: (2021)

Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes
por: Beck, Dominik, et al.
Publicado: (2011)

Characteristics of the four subtypes of myelodysplastic/myeloproliferative neoplasms
por: WU, HUANLING, et al.
Publicado: (2013)

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
por: Romano, Michela, et al.
Publicado: (2017)

Role of non‑coding RNAs in cartilage endplate (Review)
por: Zhao, Xiaokun, et al.
Publicado: (2023)

Roles of long non-coding RNAs in plant immunity
por: Huang, Juan, et al.
Publicado: (2023)

The Role of Long Non-Coding RNAs in Cardiovascular Diseases
por: Le, Linh T. T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d5qoreqpcanidcvj4v38g40gam